Biotech Archives - Feedback


Petroleum and Natural Gas Minister Dharmendra Pradhan has said India is a happening place as it is offering Rs 1000 billion business in bio-fuel and bio-energy to the investors across the globe. “India is a happening place for energy. Every day 40 million people are going to hydrocarbon retail points to meet their demand, and […]

Assam government has started a process to set up a technology incubation centre at Guwahati Biotech Park, seeking to promote new businesses in biotechnology and allied areas. Initiative will facilitate faster penetration of biotech industry and accelerate research & development activities in biotechnology and related fields with effective utilisation of the rich natural resources of […]

The West Bengal Government has taken up a project to set up three biotechnology hubs across the state to bring in more biotechnology innovations to the State. The three proposed biotechnology hubs will come in Bardhaman, Kalimpong and Medinipur districts; they will help in the co-ordination of various departments with the Biotechnology Department in a […]

Ticel Biopark III in Coimbatore, the third such park in Tamil Nadu, is expected to be ready in 18 months, said Tamil Nadu Industry Secretary CV Sankar. Tamil Nadu was one of the first States to establish a biopark (Ticel I) for pharmaceutical and life science sectors in 2004, he said at the Indo-US Partnership […]

Biotech major Biocon will invest Rs. 1,060 crore to set up a manufacturing plant near Bengaluru. At a meeting held earlier this week, headed by Karnataka Chief Minister Siddaramaiah, the State government cleared the company’s proposal to set up a plant to manufacture injectables, monoclonal antibodies and oral solid dosage (OSD) forms as part of […]

Some of India’s bigger pharmaceutical companies are ramping up investment to grow their biotechnology business. Biocon has invested $200 million in an insulin manufacturing unit in Malaysia. Lupin and Wockhardt are increasing their investments to produce new insulins and biosimilars (officially approved versions of original ‘innovator’ products, which can be manufactured when the original product’s […]